This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Abbott Laboratories rose 3.7% to $131.35 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.3% to 5,693.31 and Dow Jones Industrial Average falling 0.4% to 42,299.70.
This was the stock's second consecutive day of gains.
Abbott Laboratories closed 7.0% below its 52-week high of $141.23, which the company achieved on March 4th.
The stock outperformed some of its competitors, as Johnson & Johnson rose 0.9% to $163.13, Pfizer Inc. fell 0.8% to $25.01, and Merck & Co. Inc. fell 0.58% to $87.60.
Trading volume totaled 8.4 million, compared to the 50-day average of 7.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 27, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。